Ototoxici of high-dose carboplatin

被引:11
|
作者
Chevreau, C [1 ]
Thomas, F [1 ]
Couteau, C [1 ]
Dalenc, F [1 ]
Mourey, L [1 ]
Chatelut, E [1 ]
机构
[1] Inst Claudius Regaud, Toulouse, France
关键词
D O I
10.1200/JCO.2005.05.348
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:3649 / 3650
页数:2
相关论文
共 50 条
  • [41] Recurrence of SIADH after a high-dose regimen of thiotepa, carboplatin, and etoposide phosphate
    Kleta, R
    Wagner, A
    Jurgens, H
    MEDICAL AND PEDIATRIC ONCOLOGY, 1998, 31 (02): : 129 - 129
  • [42] Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin
    Huitema, ADR
    Spaander, M
    Mathôt, RAA
    Tibben, MM
    Holtkamp, MJ
    Beijnen, JH
    Rodenhuis, S
    ANNALS OF ONCOLOGY, 2002, 13 (03) : 374 - 384
  • [43] PLASMA-FREE PLATINUM PHARMACOKINETICS IN PATIENTS TREATED WITH HIGH-DOSE CARBOPLATIN
    NEWELL, DR
    SIDDIK, ZH
    GUMBRELL, LA
    BOXALL, FE
    GORE, ME
    SMITH, IE
    CALVERT, AH
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (09): : 1399 - 1405
  • [44] Tandem high-dose chemotherapy with topotecan–thiotepa–carboplatin and melphalan–etoposide–carboplatin regimens for pediatric high-risk brain tumors
    Jung Yoon Choi
    Hyoung Jin Kang
    Kyung Taek Hong
    Che Ry Hong
    Yun Jeong Lee
    June Dong Park
    Ji Hoon Phi
    Seung-Ki Kim
    Kyu-Chang Wang
    Il Han Kim
    Sung-Hye Park
    Young Hun Choi
    Jung-Eun Cheon
    Kyung Duk Park
    Hee Young Shin
    International Journal of Clinical Oncology, 2019, 24 : 1515 - 1525
  • [45] THE PHARMACOKINETICS OF HIGH-DOSE CYCLOPHOSPHAMIDE AND HIGH-DOSE ETOPOSIDE
    CUNNINGHAM, D
    CUMMINGS, J
    BLACKIE, RB
    MCTAGGART, L
    BANHAM, SW
    KAYE, SB
    SOUKOP, M
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1988, 5 (02): : 117 - 123
  • [46] Ototoxicity associated with high-dose carboplatin for patients with previously treated germ cell tumors
    Funt, Samuel A.
    Knezevic, Andrea
    Wilson, Kaamilah
    Bromberg, Maria
    Budnick, Amy
    O'Connor, Kerri L.
    Mchugh, Deaglan J.
    Larsen, Erik
    Bajorin, Dean F.
    Motzer, Robert J.
    Tonorezos, Emily S.
    Patil, Sujata
    Feldman, Darren R.
    CANCER, 2023, 129 (24) : 3952 - 3961
  • [47] High-Dose Carboplatin-Irinotecan-Temozolomide: Treatment Option for Neuroblastoma Resistant to Topotecan
    Kushner, Brian H.
    Kramer, Kim
    Modak, Shakeel
    Cheung, Nai-Kong V.
    PEDIATRIC BLOOD & CANCER, 2011, 56 (03) : 403 - 408
  • [48] Individual dosing of carboplatin based on drug monitoring in children receiving high-dose chemotherapy
    Rubie, H
    Doz, F
    Vassal, G
    Chastagner, P
    Gentet, JC
    Urien, S
    Bastian, G
    Drouard-Troalen, L
    Barberi-Heyob, M
    Catalin, J
    Chatelut, E
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (10) : 1433 - 1438
  • [49] HIGH-DOSE CARBOPLATIN WITH DIETHYLDITHIOCARBAMATE CHEMOPROTECTION IN TREATMENT OF WOMEN WITH RELAPSED OVARIAN-CANCER
    ROTHENBERG, ML
    OSTCHEGA, Y
    STEINBERG, SM
    YOUNG, RC
    HUMMEL, S
    OZOLS, RF
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (18) : 1488 - 1492
  • [50] ESCALATING HIGH-DOSE CARBOPLATIN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN SOLID TUMORS
    PICO, JL
    IBRAHIM, A
    CASTAGNA, L
    BOURHIS, JH
    CHAZARD, M
    MARANINCHI, D
    DROZ, JP
    ONCOLOGY, 1993, 50 : 47 - 52